Price
CHART BY
Frequently asked questions
What is Edwards Lifesci's market capitalization?
The market capitalization of Edwards Lifesci is $52.00B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Edwards Lifesci's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Edwards Lifesci is 53.53. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Edwards Lifesci?
Edwards Lifesci's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.685. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Edwards Lifesci's stock?
Currently, 29 analysts cover Edwards Lifesci's stock, with a consensus target price of $102.17. Analyst ratings provide insights into the stock's expected performance.
What is Edwards Lifesci's revenue over the trailing twelve months?
Over the trailing twelve months, Edwards Lifesci reported a revenue of $6.51B.
What is the EBITDA for Edwards Lifesci?
Edwards Lifesci's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $2.02B. EBITDA measures the company's overall financial performance.
What is the free cash flow of Edwards Lifesci?
Edwards Lifesci has a free cash flow of $1.43B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Edwards Lifesci have, and what sector and industry does it belong to?
Edwards Lifesci employs approximately 16,000 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Edwards Lifesci's shares?
The free float of Edwards Lifesci is 569.37M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $52.00B
- EPS (TTM)
- $1.685
- Free Float
- 569.37M
- P/E ratio (TTM)
- 53.53
- Revenue (TTM)
- $6.51B
- EBITDA (TTM)
- $2.02B
- Free Cashflow (TTM)
- $1.43B
Pricing
- 1D span
- $89.67$90.39
- 52W span
- $72.32$96.19
Analyst Ratings
The price target is $102.17 and the stock is covered by 29 analysts.
Buy
23
Hold
6
Sell
0
Information
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
- Employees
- 16,000
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- Primary Ticker
- EW
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet